鋭明技術(002970.SZ):公司對海外市場的未來增長充滿信心
格隆匯1月23日丨鋭明技術(002970.SZ)1月22日在接待機構投資者調研時表示,從去年海外銷售收入的整體情況來看,公司對海外市場的未來增長充滿信心。海外市場的主要增長動力來源主要來自於海外整體的經濟景氣度及需求較為旺盛。公司在美國校車市場的佔有率較高,一方面取決於公司產品較高的技術含量,另一方面得益於公司產品的性價比優勢。公司正在研製的符合新的法規要求的校車產品,可以提高單車價值,這些法規將會為公司帶來新的機會。此外,公司在貨運領域也取得了一定的成果,目前海外市場的貨運智能化滲透率尚不高,隨着技術的發展和需求的增加,公司的解決方案正在滿足海外市場對效率提升的需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.